predicting pathological complete response in breast cancer
Published 3 years ago • 577 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:19
predicting mk-2206 response in patients with breast cancer
-
1:29
the genetics of breast cancer complete response
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
5:55
utilizing pathologic complete response in breast cancer trials
-
1:13
predictive markers of response to durvalumab w/nab-paclitaxel doxorubicin/cyclophosphamide in tnbc
-
3:17
multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
-
2:13
changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
1:33
anti-müllerian hormone as a predictor of chemotherapy response in hr /her2- breast cancer
-
2:27
neoaltto: her2/cep17 ratio as a predictive biomarker in her breast cancer
-
2:49
her2-e pcr with anti-her2-based neoadjuvant therapies
-
1:55
predictive biomarkers in breast cancer
-
1:17
dr. burstein discusses pathological complete response
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
1:45
association of pathologic complete response following neoadjuvant chemotherapy with longterm sur...
-
1:59
effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
2:51
personalized ctdna during neoadjuvant therapy in pts with early-stage breast cancer
-
1:42
her2dx and pcr in her2-positive breast cancer: a combined analysis of 4 neoadjuvant studies